The Hastings Center Report

July - August 2014

Vol. 44, No. 4


Editor's Podcast

This podcast player requires theAdobe Flash plug-in. You may also download the MP3 file via the podcast feed.


Order the Hastings Center Report
Latest Commentary
Health Policy

Responding to Ebola: Organizational Ethics, Frontline Perspectives

Chelsea Jack and Nancy Berlinger, 09/09/2014
Beyond crucial questions of fair access to scarce supplies of the experimental drug ZMapp and to other potentially effective drugs to treat Ebola, commentators...
Health Policy

FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care

Rachel Sachs, 09/04/2014
Wendy Chung’s commentary last month about the FDA’s proposed draft guidance for the regulation of laboratory-developed tests (LDTs) is heavily critical of the ...
Public Health

Responding to Ebola: Fostering Transparency and Inclusivity

Keymanthri Moodley, 09/03/2014
Media reports indicate that seven individuals have received ZMapp to date, two of whom have died. The first recipients were two American health care workers fr...
Recent Commentary
Health Policy

Responding to Ebola: Selected Commentaries on Key Ethical Questions

Susan Gilbert and Nancy Berlinger, 08/22/2014
Health Care

More French Paradoxes

Susan Gilbert, 08/08/2014

Facebook’s Emotion Experiment: Implications for Research Ethics

Robert Klitzman and Paul S. Appelbaum, 07/21/2014
Science and Society

Nature Isn’t What It Used To Be

Gregory E. Kaebnick, 07/17/2014
Human Rights

What Do We Owe to Child Migrants?

Rachel Fabi and Mohini Banerjee, 06/26/2014
Science and Society

Chronicling the Tuskegee Syphilis Study Through Art

Obiora N. Anekwe, 06/12/2014
Connect with the Forum

Get Permissions

RSS feed

What is Bioethics Forum?
Bioethics Forum, the blog of the Hastings Center Report, publishes thoughtful commentary from a range of perspectives on timely issues in bioethics. The opinions expressed in it are those of the authors and not The Hastings Center.
On The Web

Journal editor defends retraction of GMO-rats study while authors reveal some of paper's history

Retraction Watch

"...claiming COPE guidelines somehow supports the decision [to retract] doesn't seem valid."

Big Data + Big Pharma = Big Money 

Charles Ornstein, ProPublica

"Need another reminder of how much drugmakers spend to discover what doctors are prescribing? Look no further than new documents from the leading keeper of such data."

U Faculty Calls for Review of Controversial Drug Study

Jeremy Olson, Star Tribune

 "Nearly a decade after Dan Markingson died by suicide while participating in a U of M drug trial for schizophrenics, the U’s Faculty Senate raised his death as a reason to re-examine their institution’s handling of vulnerable research subjects."  

 Make Your Wishes Known 

Ashwaq Masoodi, The Atlantic
The story of a 36-year-old man on life support whose family pulled the plug, and what happened next."

Transforming Diagnosis
Thomas Insel, National Institute of Mental Health
"While DSM has been described as a “Bible” for the field, it is, at best, a dictionary, creating a set of labels and defining each."